Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106


Endometrial thickness and risk of breast and endometrial carcinomas in the prostate, lung, colorectal and ovarian cancer screening trial.

Felix AS, Weissfeld JL, Pfeiffer RM, Modugno F, Black A, Hill LM, Martin J, Sit AS, Sherman ME, Brinton LA.

Int J Cancer. 2014 Feb 15;134(4):954-60. doi: 10.1002/ijc.28404. Epub 2013 Aug 28.


Transvaginal ultrasound measurement of endometrial thickness as a biomarker for estrogen exposure.

Sit AS, Modugno F, Hill LM, Martin J, Weissfeld JL.

Cancer Epidemiol Biomarkers Prev. 2004 Sep;13(9):1459-65.


Assessing the malignant potential of ovarian inclusion cysts in postmenopausal women within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a prospective cohort study.

Sharma A, Gentry-Maharaj A, Burnell M, Fourkala EO, Campbell S, Amso N, Seif MW, Ryan A, Parmar M, Jacobs I, Menon U; UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).

BJOG. 2012 Jan;119(2):207-19. doi: 10.1111/j.1471-0528.2011.03038.x. Epub 2011 Jul 15.


Prospective longitudinal study of ultrasound screening for endometrial abnormalities in women with breast cancer receiving tamoxifen.

Fung MF, Reid A, Faught W, Le T, Chenier C, Verma S, Brydon E, Fung KF.

Gynecol Oncol. 2003 Oct;91(1):154-9.


Risk prediction for breast, endometrial, and ovarian cancer in white women aged 50 y or older: derivation and validation from population-based cohort studies.

Pfeiffer RM, Park Y, Kreimer AR, Lacey JV Jr, Pee D, Greenlee RT, Buys SS, Hollenbeck A, Rosner B, Gail MH, Hartge P.

PLoS Med. 2013;10(7):e1001492. doi: 10.1371/journal.pmed.1001492. Epub 2013 Jul 30.


Cigarette smoking, physical activity, and alcohol consumption as predictors of cancer incidence among women at high risk of breast cancer in the NSABP P-1 trial.

Land SR, Liu Q, Wickerham DL, Costantino JP, Ganz PA.

Cancer Epidemiol Biomarkers Prev. 2014 May;23(5):823-32. doi: 10.1158/1055-9965.EPI-13-1105-T. Epub 2014 Feb 25.


Endogenous estrogens and the risk of breast, endometrial, and ovarian cancers.

Brown SB, Hankinson SE.

Steroids. 2015 Jul;99(Pt A):8-10. doi: 10.1016/j.steroids.2014.12.013. Epub 2014 Dec 30. Review.


Effects of adjuvant tamoxifen on the endometrium in postmenopausal women with breast cancer: a prospective long-term study using transvaginal ultrasound.

Gerber B, Krause A, Müller H, Reimer T, Külz T, Makovitzky J, Kundt G, Friese K.

J Clin Oncol. 2000 Oct 15;18(20):3464-70.


Bazedoxifene effects on the reproductive tract in postmenopausal women at risk for osteoporosis.

Pinkerton JV, Archer DF, Utian WH, Menegoci JC, Levine AB, Chines AA, Constantine GD.

Menopause. 2009 Nov-Dec;16(6):1102-8. doi: 10.1097/gme.0b013e3181a816be.


Body weight at age 20 years, subsequent weight change and breast cancer risk defined by estrogen and progesterone receptor status--the Japan public health center-based prospective study.

Suzuki R, Iwasaki M, Inoue M, Sasazuki S, Sawada N, Yamaji T, Shimazu T, Tsugane S; Japan Public Health Center-based Prospective Study Group.

Int J Cancer. 2011 Sep 1;129(5):1214-24. doi: 10.1002/ijc.25744. Epub 2011 Apr 8.


The Risks for Ovarian, Endometrial, Breast, Colorectal, and Other Cancers in Women With Newly Diagnosed Endometriosis or Adenomyosis: A Population-Based Study.

Kok VC, Tsai HJ, Su CF, Lee CK.

Int J Gynecol Cancer. 2015 Jul;25(6):968-76. doi: 10.1097/IGC.0000000000000454.


The rs1800716 variant in CYP2D6 is associated with an increased double endometrial thickness in postmenopausal women on tamoxifen.

Dieudonné AS, Lambrechts D, Smeets D, Belmans A, Wildiers H, Paridaens R, Hyonil C, Timmerman D, Christiaens MR, Vergote I, Neven P.

Ann Oncol. 2014 Jan;25(1):90-5. doi: 10.1093/annonc/mdt399. Epub 2013 Nov 20.


Breast cancer epidemiology according to recognized breast cancer risk factors in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Cohort.

Lacey JV Jr, Kreimer AR, Buys SS, Marcus PM, Chang SC, Leitzmann MF, Hoover RN, Prorok PC, Berg CD, Hartge P; Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Project Team.

BMC Cancer. 2009 Mar 17;9:84. doi: 10.1186/1471-2407-9-84.


Endometrial thickness measured by ultrasonography in postmenopausal patients with endometrial carcinoma has significance, irrespective of histological subtype.

Hosoi A, Ueda Y, Shindo M, Nakagawa S, Matsuzaki S, Kobayashi E, Kimura T, Yoshino K, Fujita M, Kimura T.

Int J Gynecol Cancer. 2013 Sep;23(7):1266-9. doi: 10.1097/IGC.0b013e31829f1857.


Endometrial evaluation in postmenopausal breast cancer patients receiving tamoxifen: an ultrasound, color flow Doppler, hysteroscopic and histological study.

Exacoustos C, Zupi E, Cangi B, Chiaretti M, Arduini D, Romanini C.

Ultrasound Obstet Gynecol. 1995 Dec;6(6):435-42.


How thick is too thick? When endometrial thickness should prompt biopsy in postmenopausal women without vaginal bleeding.

Smith-Bindman R, Weiss E, Feldstein V.

Ultrasound Obstet Gynecol. 2004 Oct;24(5):558-65.


Bazedoxifene, a selective estrogen receptor modulator: effects on the endometrium, ovaries, and breast from a randomized controlled trial in osteoporotic postmenopausal women.

Archer DF, Pinkerton JV, Utian WH, Menegoci JC, de Villiers TJ, Yuen CK, Levine AB, Chines AA, Constantine GD.

Menopause. 2009 Nov-Dec;16(6):1109-15. doi: 10.1097/gme.0b013e3181a818db.


The prevention of breast cancer through reduced ovarian steroid exposure.

Spicer DV, Pike MC.

Acta Oncol. 1992;31(2):167-74. Review.


Circulating adipokine levels and endometrial cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial.

Luhn P, Dallal CM, Weiss JM, Black A, Huang WY, Lacey JV Jr, Hayes RB, Stanczyk FZ, Wentzensen N, Brinton LA.

Cancer Epidemiol Biomarkers Prev. 2013 Jul;22(7):1304-12. doi: 10.1158/1055-9965.EPI-13-0258. Epub 2013 May 21.

Items per page

Supplemental Content

Write to the Help Desk